niacin has been researched along with Hyperlipoproteinemia Type I in 6 studies
Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
Hyperlipoproteinemia Type I: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niacin was started after recurrence." | 1.36 | Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report. ( Lupattelli, G; Mannarino, E; Roscini, AR; Siepi, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brahm, AJ | 1 |
| Hegele, RA | 1 |
| Lupattelli, G | 1 |
| Roscini, AR | 1 |
| Siepi, D | 1 |
| Mannarino, E | 1 |
| FAIVRE, G | 1 |
| GILGENKRANTZ, JM | 1 |
| CHERRIER, F | 1 |
| HENRY, C | 1 |
| van der Wel, AM | 1 |
| Castro Cabezas, M | 1 |
| de Bruin, TW | 1 |
| Erkelens, DW | 1 |
| Gotto, AM | 1 |
| Jones, PH | 1 |
| Scott, LW | 1 |
| Schaefer, EJ | 1 |
| Levy, RI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for niacin and Hyperlipoproteinemia Type I
| Article | Year |
|---|---|
Chylomicronaemia--current diagnosis and future therapies.
Topics: Benzimidazoles; Diet Therapy; Fibric Acids; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reduc | 2015 |
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia].
Topics: Arteriosclerosis; Chylomicrons; Diet, Reducing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibito | 1994 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr | 1986 |
Pathogenesis and management of lipoprotein disorders.
Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylom | 1985 |
2 other studies available for niacin and Hyperlipoproteinemia Type I
| Article | Year |
|---|---|
Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fluorobenzenes; Humans; Hydroxymethylglutaryl-Co | 2010 |
[FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
Topics: Adrenocorticotropic Hormone; Cortisone; Diagnosis, Differential; Diet; Diet Therapy; Dietary Fats; E | 1963 |